‌

US Patent RE49517 Pyrazoles

Patent RE49517 was granted and assigned to Janssen Pharmaceuticals on May, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Janssen Pharmaceuticals

Current Assignee

Janssen Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

RE495170

Patent Inventor Names

Christian Grunwald0

Barbara Langen0

Ute Egerland0

Thorsten Hage0

Simon Ward0

Rudolf Schindler0

Rita Dost0

Norbert Höfgen0

...

Date of Patent

May 2, 2023

Patent Application Number

171248790

Date Filed

December 17, 2020

Patent Citations

‌

US Patent 10617676 Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GluN2B receptor modulators

‌

US Patent 10071988 Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

Patent Primary Examiner

CPC Code

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent RE49517 Pyrazoles

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API